-
1
-
2
RNA Editing and Drug Discovery for Cancer Therapy
Published 2013-01-01“…Recently, RNA editing has been recognized as a target for drug discovery although few studies targeting RNA editing for disease and cancer therapy were reported in the field of natural products. …”
Get full text
Article -
3
A guide for active learning in synergistic drug discovery
Published 2025-01-01“…Abstract Synergistic drug combination screening is a promising strategy in drug discovery, but it involves navigating a costly and complex search space. …”
Get full text
Article -
4
New strategies to enhance the efficiency and precision of drug discovery
Published 2025-02-01Subjects: “…drug discovery…”
Get full text
Article -
5
Super-resolution microscopy as a drug discovery tool
Published 2025-03-01“…Now, after nearly two decades, super-resolution microscopy has begun to address previously unmet challenges in the study of human disease and is poised to become a pivotal tool in drug discovery.…”
Get full text
Article -
6
Linking machine learning and biophysical structural features in drug discovery
Published 2025-01-01Subjects: “…drug discovery…”
Get full text
Article -
7
Unleashing the Power of Artificial Intelligence-Driven Drug Discovery in Streptomyces
Published 2024-11-01“…Graphical abstract: The role of machine learning in drug discovery from Streptomyces. …”
Get full text
Article -
8
Harnessing the power of seaweed: unveiling the potential of marine algae in drug discovery
Published 2023-12-01Subjects: Get full text
Article -
9
Malaysia’s Breakthrough in Modern Actinobacteria (MOD-ACTINO) Drug Discovery Research
Published 2022-09-01Get full text
Article -
10
Caution when using network partners for target identification in drug discovery
Published 2025-04-01Subjects: Get full text
Article -
11
Novel 4-aminoquinazoline derivatives as new leads for anticancer drug discovery
Published 2015-09-01Get full text
Article -
12
Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
Published 2023-01-01“…Methods. A computational drug discovery approach was performed using the AutoDock tool to identify potential MAPK3 inhibitors from 46 plant-based flavonoids. …”
Get full text
Article -
13
3D In Vitro Human Organ Mimicry Devices for Drug Discovery, Development, and Assessment
Published 2020-01-01“…Organ-on-chip devices, including in vitro modelling of 3D organoids, 3D microfabrication, and 3D bioprinted platforms, play an essential role in drug discovery, testing, and assessment. In this article, a thorough review is provided of the latest advancements in the area of organ-on-chip devices targeting liver, kidney, lung, gut, heart, skin, and brain mimicry devices for drug discovery, development, and/or assessment. …”
Get full text
Article -
14
Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery
Published 2025-01-01“…Abstract Background Large-scale pharmacogenomic resources, such as the Connectivity Map (CMap), have greatly assisted computational drug discovery. However, despite their widespread use, CMap-based methods have thus far been agnostic to the biological activity of drugs as well as to the genomic effects of drugs in multiple disease contexts. …”
Get full text
Article -
15
Exploring Fragment Adding Strategies to Enhance Molecule Pretraining in AI-Driven Drug Discovery
Published 2024-09-01Subjects: Get full text
Article -
16
Implementing enclosed sterile integrated robotic platforms to improve cell-based screening for drug discovery
Published 2025-02-01“…We offer perspective on the advantages of such custom integrated systems and their limitations in cellular screening for early drug discovery.…”
Get full text
Article -
17
-
18
Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
Published 2025-01-01“…The ability to efficiently generate, expand, and biobank PDTOs has the potential to make the clinical diversity of cancer accessible for personalized medicine assay guided therapeutic drug selection and drug discovery. We describe the miniaturization and growth in 96- and 384-well formats of a single non-tumor liver and two Hepatocellular carcinoma (HCC) organoids derived from cryopreserved PDTO cells and the application of high content imaging (HCI) to characterize the models and enhance drug sensitivity testing. …”
Get full text
Article -
19
Targeting cryptic allosteric sites of G protein-coupled receptors as a novel strategy for biased drug discovery
Published 2025-02-01“…Targeting more variable allosteric sites, which are spatially different from the highly conserved orthosteric sites, represents a novel approach in biased GPCR drug discovery, leading to innovative strategies for targeting GPCRs. …”
Get full text
Article -
20